Genomic Data Has Become a Strategic Asset: Why High-Risk Laboratories Need to Act Now

This month, Sention presented on cyber-biosecurity at the prestigious Global Health Security Conference in Kuala Lumpur. As the first dedicated cyber-biosecurity workshop delivered at the conference, it highlighted how rapidly this emerging discipline is moving from a niche concern to a strategic priority for research institutions, public health laboratories and organisations handling high-consequence biological information.

One thing became clear: biology is becoming increasingly digital, and with that transformation comes a new category of risk.

For decades, laboratories have focused on biosafety and biosecurity to protect people and valuable biological materials. Today, however, a new challenge is emerging at the intersection of biology, digital technology and cybersecurity: cyber-biosecurity.

Cyber-biosecurity is not about replacing biosafety, biosecurity or cybersecurity. Rather, it is about recognising the gaps that exist between them and understanding how the increasing convergence of biology and digital technologies is creating new vulnerabilities.

As genomic sequencing, cloud platforms, artificial intelligence and international collaboration become central to modern science, laboratories are becoming increasingly connected and data-driven. While these advances are accelerating discovery, they are also creating new opportunities for cyber criminals and state-based actors seeking access to valuable scientific information.

Recent years have seen a sharp rise in cyber-attacks targeting healthcare, research and biotechnology organisations. Ransomware groups, cybercriminal syndicates and nation-state actors are no longer focused solely on financial institutions or government agencies. High-risk laboratories and genomic facilities are increasingly attractive targets because of the unique value of the information they hold.

Why Genomic Data Matters

Unlike many forms of information, genomic data cannot simply be changed or reissued. Once compromised, it remains sensitive indefinitely.

Modern laboratories hold far more than DNA sequences. They also manage:

• Human and pathogen genomic data.
• Clinical trial information.
• Research intellectual property and unpublished findings.
• Diagnostic methodologies and analytical pipelines.
• AI models and bioinformatics tools.
• .International collaboration data and sensitive metadata.
• High-value biological inventories.

Together, these assets represent significant scientific, economic and strategic value.

For hostile actors, such information provides opportunities for espionage, intellectual property theft, competitive advantage and, potentially, deliberate manipulation and misuse. In an era of increasing strategic competition, biological data is increasingly recognised as having significant scientific, economic and strategic value.

The Consequences Extend Beyond a Cyber Incident

The impact of a cyber-attack on a laboratory goes far beyond temporary system outages.

Loss or corruption of data can undermine years of research and delay scientific outcomes. Manipulation of analytical pipelines or genomic files can compromise scientific integrity and erode confidence in results. Operational disruptions can interrupt diagnostics, surveillance programs and public health responses.

The consequences are also financial. Research delays, system recovery, regulatory obligations and reputational damage can impose significant costs on organisations.

Beyond the immediate operational and financial impacts, cyber incidents can undermine confidence in scientific outputs and erode trust among patients, research participants, collaborators and funding bodies.

Cyber-Biosecurity Is Becoming a Leadership Issue

Cyber-biosecurity is no longer solely an IT problem. Protecting valuable biological assets requires scientists, bioinformaticians, laboratory managers and technology teams to work together. Governance, cybersecurity and biosafety disciplines must increasingly converge.

Laboratory leaders should be asking:

• Which biological and digital assets are most valuable?
• What would be the impact if they were lost, stolen or manipulated?
• How secure are our cloud environments, vendors and collaborators?
• Could scientific data be altered without detection?
• Are our scientific and IT communities working together to manage risk?

Why Action Is Needed Now

The question is no longer whether research organisations and laboratories will be targeted, but whether they recognise that the convergence of biology and digital technologies has created vulnerabilities that traditional approaches were never designed to address.

Cyber-biosecurity is not simply about adding another layer of cybersecurity. It is about understanding where biological and digital risks intersect and ensuring that the experts responsible for managing them are working together.

For too long, cybersecurity and the life sciences have operated as separate disciplines. Yet genomic sequencing, AI-enabled research, cloud platforms and increasingly connected laboratory environments mean those boundaries are rapidly disappearing.

Addressing these risks requires breaking down traditional silos and bringing together scientists, bioinformaticians, laboratory leaders and cybersecurity professionals.

Cyber-biosecurity represents a convergence of two disciplines that have historically evolved independently.

As biology becomes increasingly digital, the challenge is no longer simply protecting biological materials or information systems in isolation. It is understanding where these worlds intersect and ensuring that the communities responsible for managing them are working together.

‍